0001388658-20-000113.txt : 20200604 0001388658-20-000113.hdr.sgml : 20200604 20200604161831 ACCESSION NUMBER: 0001388658-20-000113 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20200603 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200604 DATE AS OF CHANGE: 20200604 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iRhythm Technologies, Inc. CENTRAL INDEX KEY: 0001388658 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 208149544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37918 FILM NUMBER: 20943169 BUSINESS ADDRESS: STREET 1: 650 TOWNSEND STREET STREET 2: SUITE 500 CITY: San Francisco STATE: CA ZIP: 94103 BUSINESS PHONE: 415-632-5700 MAIL ADDRESS: STREET 1: 650 TOWNSEND STREET STREET 2: SUITE 500 CITY: San Francisco STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: IRhythm Technologies, Inc. DATE OF NAME CHANGE: 20110429 FORMER COMPANY: FORMER CONFORMED NAME: IRhythm Technologies Inc DATE OF NAME CHANGE: 20070201 8-K 1 irtc-20200603.htm 8-K irtc-20200603
0001388658false00013886582020-06-032020-06-03


 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 
FORM 8-K 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): June 3, 2020
iRhythm Technologies, Inc.
(Exact name of Registrant as specified in its charter) 
Delaware001-3791820-8149544
(State or other jurisdiction of
incorporation or organization)
(Commission
File Number)
(I.R.S. Employer
Identification Number)
699 8th Street, Suite 600
San Francisco, California 94103
(Address of principal executive office) (Zip Code)
(415) 632-5700
(Registrant’s telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, Par Value $0.001 Per ShareIRTCThe NASDAQ Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
 








Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 3, 2020, iRhythm Technologies, Inc. (the “Company”) and Douglas J. Devine entered into an Offer Letter for Mr. Devine to become the Company’s Chief Financial Officer, starting on June 22, 2020. The Offer Letter is attached hereto as Exhibit 10.1 and incorporated herein by reference.

Since November 2017, Mr. Devine has served as the Senior Vice President and Chief Financial Officer of GlobalFoundries, a global foundry for technology companies. From January 2014 to November 2017, Mr. Devine served as Chief Financial Officer and Sr. Vice President of UTAC Holdings Ltd., a semiconductor testing and assembly company. Mr. Devine was also Chief Financial Officer of Soraa Laser Diode, Inc., a lighting company, from January 2013 to December 2013 and Stion Corp., a solar company, from February 2011 to December 2013. Mr. Devine also served as Vice President of Finance of NVIDIA Corp., a computer gaming company, from September 2009 to March 2011 and as Senior Controller of Intel Corp. from April 1997 to September 2009. Mr. Devine received an M.B.A. in Finance and a Bachelor of Science in Engineering from the University of Michigan and is also a certified public accountant.

On June 4, 2020, Matthew C. Garrett announced that he was resigning from his position as Chief Financial Officer for personal reasons, effective June 22, 2020. In connection with his resignation, Mr. Garrett and the Company will enter into a consulting agreement pursuant to which Mr. Garrett will assist with the transition of his role to Mr. Devine and consult for the Company for a period of up to one year following his resignation. Under the consulting agreement, Mr. Garrett will be paid a retainer of $10,000 per month and his outstanding equity awards will continue to vest.

The Company issued a press release regarding Mr. Garrett’s planned resignation and Mr. Devine’s agreement to join the Company as its Chief Financial Officer. The press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits
(d)Exhibits.
 




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

IRHYTHM TECHNOLOGIES, INC.
Date: June 4, 2020By:/s/ Kevin M. King
Kevin M. King
Chief Executive Officer


EX-10.1 2 irtcq220208k64ex101.htm EX-10.1 Document
Exhibit 10.1
irtclogoa022.jpg





June 3, 2020

Douglas J. Devine, CPA

Dear Doug:

We are pleased to offer you the position of Chief Financial Officer with iRhythm Technologies, Inc. (the “Company”). If you decide to join us, you will receive a salary and certain employee benefits as explained in Exhibit A. You should note that the Company may modify job titles, salaries, and benefits from time to time as it deems necessary.

In addition, if you decide to join the Company, it will be recommended at the first meeting of the Compensation Committee (the “Compensation Committee”) of the Company's Board of Directors (the “Board”) following your start date that the Company grant you equity awards with an aggregate grant date fair value of two million dollars ($2,000,000), consisting of the following:

1.An award of performance stock units (“PSUs”) covering a number of shares of the Company’s common stock with an aggregate grant date fair value of $1,000,000 which will vest pursuant to the performance-based metrics set forth in the Company’s 2020 PSU incentive program, subject to your continuing employment through the vesting date.

2.An award of restricted stock units (“RSUs”) covering a number of shares of the Company’s common stock with an aggregate grant date fair value of $1,000,000 which will vest annually over four years at the rate of twenty-five percent (25%) per year, subject to your continuing employment through each vesting date.

Each equity award will be subject to the terms and conditions of the Company's 2016 Equity Incentive Plan (as amended from time to time, the “2016 Plan”) and, as applicable, a PSU agreement or RSU agreement thereunder.

For purposes of this letter, the grant date fair value of each award will be determined in accordance with the Company’s standard equity grant practice, which typically means, with respect to awards of PSUs and RSUs, the grant date fair value will be calculated based on the thirty (30) day average closing price of the Company’s Common Stock as reported on the Nasdaq Global Select Market for the calendar month prior to your start date, or such other methodology the Board or Compensation Committee may determine prior to the grant of the awards becoming effective.

No right to any stock is earned or accrued until such time that vesting occurs, nor does the grant of the equity awards confer any right to continue vesting or employment.

The Company is excited about your joining and looks forward to a beneficial and productive relationship. Nevertheless, you should be aware that your employment with the Company is for no specified period and constitutes at-will employment. As a result, you are free to resign at any time, for any reason or for no reason. Similarly, the Company is free to conclude its employment relationship with you at any time, with or without cause, and with or without notice. We request that, in the event of resignation, you give the Company at least two weeks’ notice.

As a new employee, you will work on an introductory basis for the first ninety (90) calendar days after your date of hire. This introductory period is intended to give you the opportunity to demonstrate your ability to achieve a satisfactory level of performance and to determine whether the new position meets your expectations. The Company uses this period to evaluate your capabilities, work habits, and overall performance. It is also a time to get to know your fellow employees, your manager, company culture and the tasks involved in your job position, as well as to become familiar with the Company’s products and services. This introductory period does not affect your at-will employment status, meaning that the employment relationship may be terminated at any time and for any non-discriminatory reason by either party.

The Company reserves the right to conduct background investigations and/or reference checks on all of its potential employees. Your job offer, therefore, is contingent upon a clearance of such a background investigation and/or reference check, if any.



Exhibit 10.1
irtclogoa022.jpg



For purposes of federal immigration law, you will be required to provide to the Company documentary evidence of your identity and eligibility for employment in the United States. Such documentation must be provided to us within three (3) business days of your date of hire, or our employment relationship with you may be terminated.

We also ask that, if you have not already done so, you disclose to the Company any and all agreements relating to your prior employment that may affect your eligibility to be employed by the Company or limit the manner in which you may be employed. It is the Company's understanding that any such agreements will not prevent you from performing the duties of your position and you represent that such is the case. Moreover, you agree that, during the term of your employment with the Company, you will not engage in any other employment, occupation, consulting or other business activity directly related to the business in which the Company is now involved or becomes involved during the term of your employment, nor will you engage in any other activities that conflict with your obligations to the Company. Similarly, you agree not to bring any third party confidential information to the Company, including that of your former employer, and that in performing your duties for the Company you will not in any way utilize any such information.

As a Company employee, you will be expected to abide by the Company's rules and standards. As a condition of your employment, you are also required to sign and comply with an At‑Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement (“CIIAA”) which requires, among other provisions, the assignment of patent rights to any invention made during your employment at the Company, and non‑disclosure of Company proprietary information. In the event of any dispute or claim relating to or arising out of our employment relationship, you and the Company agree that (i) any and all disputes between you and the Company will be fully and finally resolved by binding arbitration, (ii) you are waiving any and all rights to a jury trial but all court remedies will be available in arbitration, (iii) all disputes will be resolved by a neutral arbitrator who will issue a written opinion, (iv) the arbitration will provide for adequate discovery, and (v) the Company will pay all the arbitration fees, except an amount equal to the filing fees you would have paid had you filed a complaint in a court of law. Please note that we must receive your signed CIIAA before your first day of employment.

To accept the Company's offer, please sign and date this letter in the space provided below. If you accept our offer, we anticipate your first day of employment will be Monday, June 22, 2020. This letter, along with any agreements relating to proprietary rights between you and the Company, set forth the terms of your employment with the Company and supersede any prior representations or agreements including, but not limited to, any representations made during your recruitment, interviews or pre‑employment negotiations, whether written or oral. This letter, including, but not limited to, its at‑will employment provision, may not be modified or amended except by a written agreement signed by the President of the Company and you. This offer of employment will terminate if it is not accepted, signed and returned by Thursday, June 4, 2020. An At-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement will follow in a separate communication should you decide to accept.

We look forward to your favorable reply and to working with you at iRhythm Technologies, Inc.

Sincerely,

/s/ Kevin M. King
Kevin M. King
Chief Executive Officer


Agreed to and accepted:
Signature:/s/ Douglas Devine
Printed Name: Douglas Devine
Date:June 3, 2020







Exhibit 10.1
irtclogoa022.jpg



Exhibit A

Services and Benefits for Douglas J. Devine


Position: Chief Financial Officer

Base Pay Rate: You will be a full-time employee, with a base rate of $450,000 annually, which will be earned and payable in accordance with the Company’s payroll policy. This rate is based on your geographical work location at the time of hire, and should your work location change due to relocation, your rate of pay may be reevaluated to align with geographical market rates.

Bonus: Each calendar year, you will be eligible to earn a bonus of 60% of your annual base salary at the time of bonus payment. The bonus will be based on achievement of financial targets and/or other performance objectives set by the Company, and the earned bonus will generally be paid within 90 days after the close of a calendar year. The eligible bonus amount will be prorated for any calendar quarter in which you are not employed for an entire quarter, and you must be employed on the date that your bonus, if any, is paid in order to earn and be eligible to receive the bonus.

Signing Bonus: You will receive a one-time signing bonus in the amount of $150,000. This bonus will be paid in one lump sum on the next regularly scheduled pay date after you start employment with the Company, and all regular payroll taxes will be withheld. In the event you leave the Company within 12 months of your date of hire, due to (1) voluntary departure, (2) termination for cause, or (3) involuntary termination because of significant lack of performance, you will be responsible for reimbursing the Company for the entire signing bonus. By your signature on this offer of employment, you authorize the Company to withhold this amount ($150,000.00) from any severance and/or other final pay you receive upon termination of employment per the provision above.

Benefits and Expenses: You will be entitled to participate in the benefit plans and programs generally available from time to time to employees of the Company, subject to the terms of such plans and programs. This includes four weeks per year of Paid Time Off, in addition to specified Holidays, among other benefits.

Severance: You may be eligible to receive severance benefits in the event your employment is terminated under certain conditions pursuant to the terms of our Change of Control and Severance Policy.

EX-99.1 3 irtcq220208k64ex991.htm EX-99.1 Document
Exhibit 99.1
irtclogoa021.jpg



iRhythm Technologies Announces CFO Transition

SAN FRANCISCO, June 4, 2020 -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announced today that Douglas Devine has been appointed Chief Financial Officer (CFO), effective June 22, 2020. Mr. Devine will succeed Matthew Garrett, who has decided to step down from the role. Mr. Garrett has agreed to assist in a well-ordered transition of his CFO responsibilities and will remain at iRhythm in an advisory role for up to a year to assist with special projects.

“On behalf of everyone at iRhythm and our Board of Directors, I want to thank Matt for his many contributions during his tenure with the company, including his strong leadership through iRhythm's IPO and follow-on offering, as well as numerous other transactions that enabled our growth and positioned us well for future financial stability,” said Kevin King, CEO. “We appreciate his dedication and wish him all the best beyond iRhythm."

“It has been a privilege to serve as iRhythm’s CFO for the past seven and a half years, and to see the impact that we are making in fundamentally transforming how cardiac arrhythmias are diagnosed. I’m proud to have been part of this important healthcare advancement,” said Matthew Garrett. “It has also been an honor to have worked alongside colleagues that are truly dedicated to bringing to market superior solutions that improve the quality of life of our customers and their patients.”

Mr. King also stated, “I am delighted to welcome Doug to iRhythm. We are fortunate to have a strong finance team, and now a smooth transition plan in place with Doug immediately stepping into the CFO role. His expansive financial experience and track record leading large, complex technology organizations provides not only continuity for our team, but readily enables us to make the next stride forward in operational growth and financial performance."

Douglas Devine brings more than 25 years of financial leadership experience to iRhythm, including a track record of success in fund raising, influencing business strategy, driving cost reductions, and implementing financial systems. He joins the company from GlobalFoundries, a multi-billion dollar semiconductor foundry, where he has been the Chief Financial Officer.

“iRhythm Technologies has impressed me with its team, culture, board, unique products and growth potential,” said Douglas Devine. “I’m very excited to join the team and look forward to exciting times ahead.”

Devine holds an MBA from the University of Michigan and a BS in Engineering from the University of Michigan. He also has earned his CPA certification.

About iRhythm Technologies, Inc. iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company believes improvements in arrhythmia detection and characterization have the potential to change clinical management of patients.

Forward-Looking Statements
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. These statements include statements regarding the CFO transition and employment matters related thereto. Such statements are based on current assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. These risks and uncertainties, many of which are beyond our control, include risks described in the section entitled “Risk Factors” and elsewhere in our filing made with the Securities and Exchange Commission on the Form 10-Q on May 8, 2020. These forward-looking statements speak only as of the date hereof and should not be unduly relied upon. iRhythm disclaims any obligation to update these forward-looking statements.


Investor Relations Contact:Media Contact:
Lynn Pieper Lewis or Leigh Salvo Saige Smith
(415) 937-5404(262) 289-7065
investors@irhythmtech.comirhythm@highwirepr.com


EX-101.SCH 4 irtc-20200603.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Document and Entity Information Document link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 5 irtc-20200603_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 6 irtc-20200603_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 7 irtc-20200603_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Written Communications Written Communications Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Address Line One Entity Address, Address Line One Security Exchange Name Security Exchange Name Entity Address, Address Line Two Entity Address, Address Line Two City Area Code City Area Code Cover [Abstract] Cover [Abstract] Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity File Number Entity File Number Document Type Document Type Entity Emerging Growth Company Entity Emerging Growth Company Title of 12(b) Security Title of 12(b) Security Amendment Flag Amendment Flag Local Phone Number Local Phone Number Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code Trading Symbol Trading Symbol Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name EX-101.PRE 8 irtc-20200603_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 9 irtclogoa021.jpg begin 644 irtclogoa021.jpg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end GRAPHIC 10 irtclogoa022.jpg begin 644 irtclogoa022.jpg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end XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 1 95 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Document and Entity Information Document Sheet http://www.irhythmtech.com/role/DocumentandEntityInformationDocument Document and Entity Information Document Cover 1 false false All Reports Book All Reports irtc-20200603.htm irtc-20200603.xsd irtc-20200603_cal.xml irtc-20200603_def.xml irtc-20200603_lab.xml irtc-20200603_pre.xml irtcq220208k64ex101.htm irtcq220208k64ex991.htm http://xbrl.sec.gov/dei/2019-01-31 true true JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "irtc-20200603.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "irtc-20200603_cal.xml" ] }, "definitionLink": { "local": [ "irtc-20200603_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "irtc-20200603.htm" ] }, "labelLink": { "local": [ "irtc-20200603_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "irtc-20200603_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "irtc-20200603.xsd" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "irtc", "nsuri": "http://www.irhythmtech.com/20200603", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "irtc-20200603.htm", "contextRef": "i5c57b34eb8e840329d370b76314e090e_D20200603-20200603", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Document and Entity Information Document", "role": "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument", "shortName": "Document and Entity Information Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "irtc-20200603.htm", "contextRef": "i5c57b34eb8e840329d370b76314e090e_D20200603-20200603", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.irhythmtech.com/role/DocumentandEntityInformationDocument" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 13 0001388658-20-000113-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001388658-20-000113-xbrl.zip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report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 irtc-20200603_htm.xml IDEA: XBRL DOCUMENT 0001388658 2020-06-03 2020-06-03 0001388658 false 8-K 8-K 2020-06-03 iRhythm Technologies, Inc. DE 001-37918 20-8149544 699 8th Street Suite 600 San Francisco CA 94103 415 632-5700 false false false false Common Stock, Par Value $0.001 Per Share IRTC NASDAQ false EXCEL 16 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 17 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 19 R1.htm IDEA: XBRL DOCUMENT v3.20.1
Document and Entity Information Document
Jun. 03, 2020
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jun. 03, 2020
Entity Registrant Name iRhythm Technologies, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-37918
Entity Tax Identification Number 20-8149544
Entity Address, Address Line One 699 8th Street
Entity Address, Address Line Two Suite 600
Entity Address, City or Town San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94103
City Area Code 415
Local Phone Number 632-5700
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, Par Value $0.001 Per Share
Trading Symbol IRTC
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001388658
Amendment Flag false